Factores de éxito del tratamiento de la tuberculosis multidrogorresistente relacionados con el paciente y el personal sanitario en Colombia

Puerto Castro, Gloria Mercedes; Montes Zuluaga, Fernando Nicolás; Alcalde-Rabanal, Jacqueline Elizabeth; Pérez, Freddy.
Rev. panam. salud pública ; 45: e5, 2021. tab
Artículo en Español | LILACS | ID: biblio-1252038

Documentos relacionados

  1. Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania.
  2. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
  3. Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis.
  4. Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda.
  5. [Factors associated with underreporting of cases of multidrug-resistant tuberculosis in the state of Rio de Janeiro, Brazil: probabilistic database linkage].
  6. Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection Model.
  7. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
  8. Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents.
  9. Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments.
  10. [Cryotherapy combined with local spraying of isoniazid for the treatment of nasopharyngeal tuberculosis: a case report].